By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Exonhit today said that Almac Diagnostics will serve as the sole reference laboratory for testing performed with Exonhit's AclarusDx for Alzheimer's disease.
Registering provides access to this and other free content.
Already have an account?Login Now.
Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.
Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.
In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.
An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.